Effects of Andriol Testocaps in Symptomatic Late-Onset Hypogonadism (43203)

Inclusion Criteria: * Subjects were at least 50 years of age * A body mass index (BMI) between 18 and 34 kg/m\^2 * Symptoms of androgen deficiency (as indicated by a positive Androgen Deficiency in Aging Males (ADAM) questionnaire) * Calculated free testosterone measurement of \<0.26 nmol/L in the morning Exclusion Criteria: * History or current diagnosis of breast or prostate cancer * any clinically significant abnormal finding on physical examination including the prostate * Clinical symptoms of obstructive benign prostate hyperplasia (International Prostate Symptom Score (IPSS) \>14) * Prostate specific antigen (PSA) level \> 4 ng/mL at screening * Cause of androgen deficiency other than aging, e.g. 'classical' diagnosis of primary or secondary hypogonadism * Hyperprolactinaemia or treatment with prolactin-lowering drugs * History of known chronic polycythemia and/or hematocrit \>50% at screening * History or presence of severe sleep apnea * Unstable or untreated endocrine disorders * History or presence of clinically significant depression or other psychiatric disorder or any clinically relevant cardiovascular, cerebrovascular, endocrine, hepatic, renal or hematological disease, thromboembolism/thrombosis etc. which, in the opinion of the investigator, might compromise the subject's participation in the trial * Use of medication that would interfere with the efficacy and safety objectives of the trial